NCT02908802

Brief Summary

Subjects will answer the following questionnaire and tests:

  • Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
  • Demographic Questionnaire - composed by the researchers
  • Family Eating Habits Questionnaire (FEAHQ-33)
  • Food Frequency Questionnaire (FFQ)
  • Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 21, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

September 12, 2018

Status Verified

September 1, 2018

Enrollment Period

2.8 years

First QC Date

September 18, 2016

Last Update Submit

September 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduce symptoms of attention deficit measured by MOXO test

    After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test

    Six month

Study Arms (2)

Probiotic

ACTIVE COMPARATOR

Probiotic capsules: two capsules twice a day

Dietary Supplement: Probiotic

Placebo

PLACEBO COMPARATOR

Probiotic capsules without the active ingredient: two capsules twice a day

Dietary Supplement: Placebo

Interventions

ProbioticDIETARY_SUPPLEMENT

Probiotic

Probiotic
PlaceboDIETARY_SUPPLEMENT

Probiotics capsules without the active ingredient

Placebo

Eligibility Criteria

Age19 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist,
  • Students who are not treated by medication or alternative treatment,
  • Students who are not due to complete their education at Tel Hai College during the study period,
  • Students who have signed on an informed consent form,
  • No dairy intolerance (student can consume milk without any adverse effects),
  • No soy allergy,
  • Not currently taking any antibiotics or probiotics,
  • Not pregnant or planning to become pregnant during the study period,
  • Not been diagnosed with any of the following:
  • Cancer
  • HIV/AIDS
  • Crohn's disease
  • Ulcerative colitis
  • Immune compromised illness
  • Other serious illness

You may not qualify if:

  • Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder,
  • Students who have not been assessed by MATAL and a psychiatrist,
  • Students who take antibiotics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Snait Tamir, Professor

    snait@telhai.ac.il

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2016

First Posted

September 21, 2016

Study Start

November 1, 2016

Primary Completion

September 1, 2019

Study Completion

October 1, 2019

Last Updated

September 12, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share